OptiBiotix Health Plc (LON:OPTI – Get Free Report) insider David Blain purchased 84,053 shares of the stock in a transaction on Wednesday, October 1st. The stock was acquired at an average cost of GBX 1,175 per share, with a total value of £987,622.75.
OptiBiotix Health Trading Down 4.1%
Shares of LON OPTI opened at GBX 10.55 on Friday. The stock has a market cap of £10.90 million, a price-to-earnings ratio of -573.48 and a beta of 1.71. OptiBiotix Health Plc has a 12 month low of GBX 9 and a 12 month high of GBX 23.50. The company has a 50 day simple moving average of GBX 10.95 and a two-hundred day simple moving average of GBX 13.53.
OptiBiotix Health (LON:OPTI – Get Free Report) last announced its earnings results on Tuesday, September 16th. The company reported GBX (1.15) EPS for the quarter. OptiBiotix Health had a negative net margin of 524.43% and a negative return on equity of 36.76%.
About OptiBiotix Health
OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.
OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements.
Read More
- Five stocks we like better than OptiBiotix Health
- Best Stocks Under $10.00
- Why the Precious Metal Nobody Talks About Could Be Your Best Bet
- Transportation Stocks Investing
- Cheap Chipotle? Why CMG Stock Could Be Ready for a Comeback
- Using the MarketBeat Stock Split Calculator
- 3 Industrial Stocks Ready to Benefit From Fed Cuts and Spending
Receive News & Ratings for OptiBiotix Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health and related companies with MarketBeat.com's FREE daily email newsletter.
